Some info about human ehrlichiosis ...


  • bacterial infection

  • two potentially deadly forms, human monocytic ehrlichiosis (HME) and human granulocytic anaplasmosis (HGA)

  • estimated mortality rates are 2-5% for HME and 7-10% for HGA

  • principal vector is tick

  • most cases occur in spring and summer

  • 1 - 2 week incubation period

  • typically presents as febrile illness with nonspecific malaise, myalgia, headache, and chills.

  • 30% of HME patients will have rash, making mnemonic, "ehrlichiosis is Rocky Mountain spotted fever without spots," partially untrue

  • most common lab abnormalities are leukopenia, thrombocytopenia and elevated LFTs

  • diagnosis with indirect fluorescent antibody test; intracytoplasmic inclusions (morulae) may be noted on blood smear

  • treat with doxycycline


Source

Sexton, Daniel. "Human ehrlichiosis" Up to Date. 15 April 2008. <http://www.uptodate.com>